AI assistant
Sending…
Lunai Bioworks Inc. — Director's Dealing 2017
Sep 22, 2017
34813_dirs_2017-09-22_ac1be928-1f12-49b1-b81c-0172794ef5f0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DanDrit Biotech USA, Inc. (DDRT)
CIK: 0001527728
Period of Report: 2017-09-20
Reporting Person: Leire, Eric Jean Marie (Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-09-20 | Common Stock | A | 62687 | $1.80 | Acquired | 71302 | Direct |
More from Lunai Bioworks Inc.
Share Issue/Capital Change
2026
May 20
Interim / Quarterly Report
2026
May 15
Declaration of Voting Results & Voting Rights Announcements
2026
May 13
Delisting Announcement
2026
May 11
Capital/Financing Update
2026
May 1
Regulatory Filings
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 13
Delisting Announcement
2026
Feb 23
Interim / Quarterly Report
2026
Feb 17
Delisting Announcement
2026
Feb 12